EPIDEMIOLOGY, TREATMENT AND ECONOMIC BURDEN OF TYPE 2 DIABETES MELLITUS WITH NEPHROPATHY COMPLICATIONS IN CHINA

Author(s)

Huang YY1, Fan WJ1, Zhu JJ1, Zhan L2, Chen W31School of Public Health, Fudan University, Shanghai, China, 2Boehringer Ingelheim Shanghai Pharmaceuticals Co. Ltd., Shanghai, China, 3Fudan University, Shanghai, China

OBJECTIVES: To summarize the progress of epidemiology, treatment, and economic burdens of type 2 diabetes mellitus (T2DM) with nephropathy complications in China. METHODS: A systematic review method was performed to search and refine the evidence of existing English and Chinese researches on T2DM and diabetic nephropathy. Literatures were searched from various databases including Pubmed, Web of science, CNKI, etc. Five inclusion criteria include disease (T2DM and nephropathy), population (Chinese patients), prevalence, treatment procedure, and disease burden. Quality assessment and data extraction were implemented by two reviewers independently and the differences between them were resolved by consensus. RESULTS: Fifty-one articles were included in the review. The results showed that the rising prevalence rate of diabetes in China has reached a high level. The mortality of diabetic nephropathy (DN) has higher proportion of 34% in total mortality of T2DM patients than other DM complications, although the researches related to DN are not yet enough. The western medicine treatment strategies of T2DM with chronic kidney diseases were more instructional, while the treatment with Chinese herbal medicine was based on the principle of ‘syndrome differentiation’, resulting in the difficulty to carry out multicenter clinical researches to evaluate the treatment effect. Diabetes and its complications have brought a heavy burden in China. The total economic burden of DM and its complications reached 247.8 billion RMB in 2007 and varied among different cities and between urban and rural areas. CONCLUSIONS: Evidence of prevalence and disease burden of diabetes was not comprehensive in current researches on Chinese patients, especially for diabetic nephropathy. Information of diabetic complications should be included in the content of cross-sectional diabetes surveys to provide more information of the incidence and prevalence of DN. More intervention researches should be conducted to actively prevent DM and chronic complications such as DN.

Conference/Value in Health Info

2012-09, ISPOR Asia Pacific 2012, Taipei, Taiwan

Value in Health, Vol. 15, No. 7 (November 2012)

Code

DB1

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Health Care Research

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×